Mariam M. Gharabaghtsyan

Mariam M. Gharabaghtsyan

Auto-generated profile, based on publicly available information

Mariam M. Gharabaghtsyan

St. Petersburg State Pediatric Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2022 in Rheumatology Science and Practice
Verified
Journal Article
Open access
PDF file
IAIlia Avrusin
Ilia Avrusin
RRRinat Raupov
Rinat Raupov
NGN. T. Garipova
N. T. Garipova
MGM. M. Gharabaghtsyan
M. M. Gharabaghtsyan
SKS. V. Khrypov
S. V. Khrypov
Mikhail KostikMikhail Kostik
Mikhail Kostik
Systemic corticosteroids are continued to be administered in juvenile idiopathic arthritis (JIA) patients, especially in systemic JIA (sJIA), despite the ability of biologic therapy. One of the complications of long-term CS treatment is delayed hip arthritis development with risk of secondary hip osteoarthritis formation and total hip arthroplasty (THA).We compared different types of hip joint lesions in JIA, especially, secondary hip osteoarthritis development and THA rates in systemic and non-systemic JIA, and evaluate systemic corticosteroids contribution to those complications.The study included 753 JIA patients. They were divided into 2 groups: patients with sJIA and non-systemic JIA (nsJIA). Clinical and demographic characteristics, CS treatment regimens were compared.Results. Hip arthritis was found equally often in both groups, but both secondary hip osteoarthritis (19% vs 5,3%) and THA (8.6% vs 1.6%) prevailed in the sJIA. Patients with sJIA had delayed hip involvement (57.9% vs 30.6%; p=0.019), earlier secondary hip osteoarthritis development (4.5 vs 5.1 years after the JIA onset) with younger age of secondary hip osteoarthritis achievement (13.7 vs 15.2 years; р=0.045), they also had higher inflammatory activity, greater systemic corticosteroids administration (94.8% vs 56.1%; р=0.0000001) and higher cumulative systemic corticosteroids dose (3085 mg vs 2000 mg; p=0,005). More than half patients (56.1%) with nsJIA had systemic corticosteroids treatment and impaired calcium-phosphorus metabolism.Conclusion. Systemic corticosteroid treatment and delayed hip involvement are independent predictors of secondary hip osteoarthritis in all JIA categories. Calcium and phosphate metabolism disturbances are additional predictor for secondary hip osteoarthritis in non-systemic JIA categories

13 April 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
Mikhail KostikMikhail Kostik
Mikhail Kostik
EIE.A. Isupova
E.A. Isupova
MRM.V. Rumyantseva
M.V. Rumyantseva
NGN.T. Garipova
N.T. Garipova
MGM.M. Gharabaghtsyan
M.M. Gharabaghtsyan
TLT.S. Likhacheva
T.S. Likhacheva
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.

1 June 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
LSLubov Sorokina
Lubov Sorokina
RRRinat Raupov
Rinat Raupov
IAI. Avrusin
I. Avrusin
MGM. Gharabaghtsyan
M. Gharabaghtsyan
NGN. Garipova
N. Garipova
Mikhail KostikMikhail Kostik
Mikhail Kostik
Background: Hip osteoarthritis (HOA) is a severe irreversible complication of patients with juvenile idiopathic arthritis (JIA) leads to intensive pain, disability and required total hip arthroplasty (THA) in childhood or in the young adults. Objectives: the aim of our study was to evaluate risk factors of HOA in JIA patients. Methods: we analyzed 753 patients with JIA for last 10 years. In each patient we observed if the HOA developed or no. We evaluated the main clinical JIA measurements, such a JIA category, CRP, ESR, WBC, PLT, active joints, initial or delayed hip involvement, ANA, HLA B27, onset age, JIA duration, time before HOA and before THA, bone metabolic markers, treatment, particularly glucocorticosteroids (GCS), their cumulative doses, route of administration (oral, intra-articular, pulse therapy). HOA was confirmed with radiological assessment (MRI and CT). For comparison analysis used nonparamentric statistics. Each possible variable was evaluated with univariate regression analysis and further multiple regression analysis was applied. Results: the comparative study between 2 groups shown in the table 1. HOA was detected in 48 (6.4%), in oligoarthritis-0%, in polyarthritis - 4.9%, in psoriatic arthritis - 5.0%, in enthesitis-related arthritis -11.8%, in systemic arthritis 19% (p=0.0000001), THA was performed in 16 (2.1%). Hip involvement at onset of JIA was similar in both groups (49.5% vs 41.7%, p=0.367). Characteristics of JIA patients, depends on HOA development. Cutt-offs, odds ratio for HOA risk factors in JIA patients. Conclusion: the main risk factors of HOA were increased inflammatory activity, systemic arthritis, HLA B27, systemic corticosteroids, delayed remission and biologics, decreased bone metabolism. Delayed hip involvement underline the possible non-inflammatory mechanism of HOA, such as avascular necrosis. Disclosure of Interests: None declared

18 February 2020 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
NGNina T. Garipova
Nina T. Garipova
MGMariam M. Gharabaghtsyan
Mariam M. Gharabaghtsyan
LSLubov Sorokina
Lubov Sorokina
Mikhail KostikMikhail Kostik
Mikhail Kostik
Гравитационная эритема: клиническое наблюдение и дифференциальная диагностика